Articles On Thc Global Group (ASX:THC)

In the wake of THC Global (ASX: THC) reporting it has secured its medicinal cannabis manufacturing licence, partner Eve Investments (ASX: EVE) noted the licence now paves the way for the duo to advance existing site lease, tea-tree and cann...

Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the...

Medical cannabis is becoming popular in the pharmaceutical industry, with more and more countries legalising cannabis for its use as a medicinal product. Growing number of research bodies are supporting the use of cannabis and cannabis-base...

THC Global’s (ASX: THC) wholly-owned subsidiary Canndeo has achieved a major milestone by securing a manufacturing licence to produce cannabis extracts and tinctures in Australia. The Australian Office of Drug Control granted the licence to...

One area of the share market that is performing better than most on Thursday is the cannabis industry. A number of cannabis-related shares are trading notably higher today. Two in particular that have caught the eye are listed below. Here’s...

THC Global Group (ASX: THC) now has a manufacturing licence but it’s not for its prized Southport site. The licence, which allows THC to produce medicinal cannabis products, has been granted for its Bundaberg site in Queensland. THC is now...

One of Australia's leading listed cannabis companies is on track with its 'farm to pharma' business model after crossing a key regulatory hurdle. Shares in THC Global (ASX: THC) rose 12.5 per cent this morning to $0.50 after the company a...

While several countries across the world are waking up to the benefits of medicalised/legalised marijuana, the industry has boomed rapidly and is one of the fastest growing markets in the world. Meanwhile, Australia’s cannabis market is als...